DANA CARNS: Open Payments
NPI 1033865852 · CHANDLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 49 payments from 16 companies in 2025. Trend: 2023 $463 · 2024 $1,239 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $142 |
| Exact Sciences Corporation | 6 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $110 |
| PFIZER INC. | 5 | $104 |
| Astellas Pharma US Inc | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
Products named: MOUNJARO, Kerendia, ELIQUIS, Cologuard Collection Kit, JARDIANCE, Veozah, REXULTI, GEMTESA.
Industry payments across TX — which companies pay providers there.
